Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

NCT02467452 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1479

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: BDP/FF/GB
DRUG: FlF/VI + Tiotropium

Sponsor

Chiesi Farmaceutici S.p.A.